EPISIL, created in 2008 (Sweden), from 9 sister brands and 2214 competing brands. EPISIL is owned by CAMURUS AB NPV, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is SE0007692850. EPISIL is part of the Biotechnology activity sector.

EPISIL is a brand of CAMURUS AB NPV (7CA) Share price

International deposit : 2008 Business sector Biotechnology

Share price and profitability of the share CAMURUS AB NPV (EPISIL)

Buy CAMURUS AB NPV share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 40.90

Portfolio valuation
CAMURUS AB NPV (EPISIL) over 5 years* EUR 249.80

Stock market history CAMURUS AB NPV (EPISIL)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
CAMURUS AB NPV

See more brands of CAMURUS AB NPV

Rival brands
EPISIL

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS